1 year return (CAGR)
16.24%
INmune Bio Inc Exchange (NASDAQ, USD)
INMB
2.29
-0.04 (-1.72%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-34.74%
5 year return (CAGR)
-34.73%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
63.56M
Price/Sales
-
Ent value
51.63M
Price/Book
3.12
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.35 |
| Daily high | 2.42 |
| Daily low | 2.29 |
| Daily Volume | 307K |
| All-time high | 27.85 |
| 1y analyst estimate | 7.00 |
| Beta | 0.90 |
| EPS (TTM) | -0.69 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| INMB | S&P500 | |
| Current price drop from All-time high | -91.78% | -0.56% |
| Highest price drop | -95.98% | -56.47% |
| Date of highest drop | 27 Mar 2026 | 9 Mar 2009 |
| Avg drop from high | -61.75% | -10.68% |
| Avg time to new high | 91 days | 12 days |
| Max time to new high | 1265 days | 1805 days |
News
